Stocks · Health care · Biological Products, (No Diagnostic Substances)

Vir Biotechnology, Inc.

VIR Clue Score34

United States Fiscal year ends December CIK 0001706431 Results filed 4 Nov 2026

Add to watchlist

What the insiders did Net selling

Individual transactions

Insider

Date

Role

Action

Price

Amount

Charles Elliott Sigal

1 Mar 2023

Director

Buy indirect

2,500

$22.73

$56.82K

Charles Elliott Sigal

5 Jan 2023

Director

Buy indirect

2,500

$24.96

$62.40K

Charles Elliott Sigal

4 Jan 2023

Director

Buy indirect

2,500

$25.25

$63.14K

Charles Elliott Sigal

3 Jan 2023

Director

Buy indirect

2,500

$25.60

$63.99K

Showing 250 of 462 transactions. The figures above use every one of them.

What was left out

Form 4 filings counted 435

Amendments (4/A) skipped 11

Filings about a different issuer 0

Unreadable filings 0

Joint filings 76

Sales on a Rule 10b5-1 plan 84

Sales straight out of an exercise 130

Sales at will 217

Transactions with no price 0

Shares from compensation/vesting 178,543,571

Sales filed before the plan box existed 178

History held since 10 Oct 2019